Knowledge levels of obstetricians and gynecologists on deep vein thrombosis

Year 2025, Volume: 11 Issue: 6, 1098 - 1107

Abdullah Burak Balcı , Ömer Faruk Rahman , Emrah Dağdeviren

https://doi.org/10.18621/eurj.1670072

Abstract

Objectives: The aim of this study was to evaluate the level of knowledge of obstetricians and gynecologists about deep vein thrombosis (DVT) in pregnancy.

Methods: A cross-sectional questionnaire comprising 12 items was administered to obstetricians and gynecologists employed at a tertiary care hospital between January 2024 and March 2024. Following a reliability analysis, a DVT questionnaire scale was developed, which was subsequently evaluated across three sub-dimensions: (1) General Disease Knowledge (F1), (2) Medical Treatment Knowledge (General) (F2), and (3) Anticoagulant Knowledge Level (F3).

Results: A total of 163 participants were evaluated in the study, with a mean age of 32.33±5.75 years. Among these individuals, 107 (65.6%) were female and 56 (34.3%) were male. Additionally, 72 (44.2%) of the participants were classified as resident physicians. The scores for the sub-dimensions of the DVT scale were as follows: 2.25±1.03 for (F1), 1.33±0.72 for (F2), and 2.53±1.09 for (F3). Notably, (F3) of the resident physicians was found to be significantly lower than that of the specialist/faculty member group, with a P-value of less than 0.017.

Conclusions: The study demonstrated that the knowledge levels of obstetricians and gynecologists fell below the established proficiency threshold. This deficiency is believed to stem from inadequate understanding of the differentiation between superficial and deep vein thrombosis, the management of anticoagulant therapy during pregnancy, and post-thrombotic syndrome. Enhancing awareness in these areas may improve patient outcomes, reduce reliance on cardiovascular surgery consultations, and alleviate clinical workload.

Keywords

Deep vein thrombosis , obstetrics and gynecology , anticoagulants , knowledge assessment , healthcare surveys

Ethical Statement

This study was approved by the Başakşehir Çam and Sakura City Hospital Clinical Research Ethics Committee (Decision no.: 2024/00345, date: 15.01.2024).

References

• 1. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9-16. doi: 10.1161/01.CIR.0000078469.07362.E6.
• 2. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-474. doi: 10.1038/nrcardio.2015.83.
• 3. James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326-331. doi: 10.1161/ATVBAHA.109.184127.
• 4. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632-637. doi: 10.1111/j.1538-7836.2008.02921.x.
• 5. Skeith L. Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation. Hematology Am Soc Hematol Educ Program. 2021;2021(1):559-569. doi: 10.1182/hematology.2021000291.
• 6. Zullo F, Di Mascio D, Berghella V. Evidence-based labor management: postpartum care after vaginal delivery (part 6). Am J Obstet Gynecol MFM. 2023;5(7):100977. doi: 10.1016/j.ajogmf.2023.100977.
• 7. Turton EP, Coughlin PA, Berridge DC, Mercer KG. A survey of deep venous thrombosis management by consultant vascular surgeons in the United Kingdom and Ireland. Eur J Vasc Endovasc Surg. 2001;21(6):558-563. doi: 10.1053/ejvs.2001.1317.
• 8. Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist. 2003;8(4):381-388. doi: 10.1634/theoncologist.8-4-381.
• 9. National Treatment Guidelines for Peripheral Arterial and Venous Diseases. Editor: A. Kürşat Bozkurt. Bayçınar Medical Publishing and Advertising Trade Ltd. Co.:İstanbul. 2021.
• 10. Cook D, Meade M, Guyatt G, et al.; Canadian Critical Care Trials Group. Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists. Crit Care. 2004;8(3):R145-52. doi: 10.1186/cc2859.
• 11. Zhao Y, Li B, Qin H, et al. Knowledge of deep vein thrombosis among nursing interns: A cross-sectional study. Nurse Educ Pract. 2024;75:103915. doi: 10.1016/j.nepr.2024.103915.
• 12. Alyousef HA, Badawi SEA, Elghoneimy YA, Alameri RA, Almutairi AM. Nurses' Knowledge and Practices Regarding the Prevention of Deep Vein Thrombosis in Saudi Arabia: Descriptive Cross-Sectional Study. Med Arch. 2022;76(6):447-453. doi: 10.5455/medarh.2022.76.447-453.
• 13. Atılgan K, Demirdaş E, Er CZ, Çiçekçioğlu F. Evaluation of deep vein thrombosis incidence with respect to age and gender in light of regional factors in central Anatolia: A population-based study. J Surg Med. 2020;4(1):62-65. doi: 10.28982/josam.643503.
• 14. Cayley WE Jr. Preventing deep vein thrombosis in hospital inpatients. BMJ. 2007;335(7611):147-151. doi: 10.1136/bmj.39247.542477.